ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/15/2025
Back to search
Official data from USPTO
GENLINK3D
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GENLINK3D
ST13
US500000097691779Class
9, 35, 42
Filing
97691779
Registration
7895843
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
10/16/2025
Trademark type
Word
Nice classes
9, 35, 42
Filing date
11/25/2022
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
10/16/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
78
Owner location
CAMBRIDGE, GB
Examiner
ANDERSON,DANIELLE LYNN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
E. G. (pessoa física)
ENHANC3D GENOMICS LTD
Representatives
Emily M. Chilson ANDRUS INTELLECTUAL PROPERTY LAW, LLP
Technical classification
Nice Classes
Class 9Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Downloadable software for visualisationanalysismanipulation of biological molecules in the field of genomics; Downloadable software for visualisationanalysismanipulation of biological molecules; Downloadable software for modelling and prediction of biological interactions; Downloadable software for genome sequencing; Scientific research apparatus and instruments being laboratory devices for detecting genetic sequences by profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Electronic database in the field of genomics recorded on computer media; Downloadable educational publicationsprintable workbooksbookletsscientific journalsarticles in the field of genomics; Downloadable electronic publications in the nature of scientific journals and articles in the field of drug discovery; Downloadable electronic publications in the nature of scientific journals and articles in the field of medical diagnosis; Downloadable electronic publications in the nature of scientific journals and articles in the field of biomarker discovery; Downloadable electronic publications in the nature of scientific journals and articles in the field of genomics; Downloadable electronic publications in the nature of scientific journals and articles in the field of bioinformatics
Class 35
Business data analysis in the field of drug discovery; Business data analysis in the field of medical diagnosis; Business data analysis in the field of biomarker discovery; Business data analysis in the field of genomics; Business data analysis in the field of bioinformatics; Data processing in the field of drug discovery; Data processing in the field of medical diagnosis; Data processing in the field of biomarker discovery; Data processing in the field of genomics; Data processing in the field of bioinformatics; Database management; Database management and statistical reporting services for business purposes; Business information services in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Business consulting services in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Business consulting services in the field of drug discovery; Business consulting services in the field of biomarker discovery; Market intelligence services in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Business advisory servicesconsultancy and information
Class 42
Software as a service (SAAS) services featuring software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Software as a service (SAAS) services featuring software for analyzing biological data for research and development of drugs in the field of genomics; Software as a service (SAAS) services featuring software for diagnosis of genetic diseases by analyzing biological data; Software as a service (SAAS) services featuring software for development of biomarkers for medical treatment; Software as a service (SAAS) services featuring software for collectionanalysis and interpretation of biological data; Software as a service (SaaS) services featuring software for visualisationanalysismanipulation of biological molecules; Software as a service (SaaS) services featuring software for modelling and prediction of biological interactions; Software as a service (SaaS) services featuring software for genome sequencing; Software as a service (SAAS) services featuring software for data analysisdata processing and database management in the field of genomics; Software as a service (SAAS) services featuring software for data analysis for research and development of artificial intelligence and machine learning in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for data analysisdata processing and database management in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for analyzing biological data for research and development of drugs in the field of genomics; Platform as a service (PAAS) featuring computer software platforms for diagnosis of genetic diseases by collecting and analyzing biological data; Platform as a service (PAAS) featuring computer software platforms for development of biomarkers for medical treatment; Platform as a service (PAAS) featuring computer software platforms for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Platform as a service (PAAS) featuring computer software platforms for collectionanalysis and interpretation of biological data; Platform as a service (PaaS) featuring computer software platforms for visualisationanalysismanipulation of biological molecules; Platform as a service (PaaS) featuring computer software platforms for modelling and prediction of biological interactions; Platform as a service (PaaS) featuring computer software platforms for genome sequencing; Platform as a service (PaaS) featuring computer software platforms for performing data analysisdata processingdatabase management in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Platform as a service (PaaS) featuring computer software platforms using artificial intelligence for machine learning in the field of genomics; Design and development of software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Design and development of computer software in the field of data analysis for drug discovery; Design and development of computer software in the field of data analysis for medical diagnosis; Design and development of computer software in the field of collection and analysis of biological data for biomarker discovery; Design and development of computer software in the field of genomic analysis; Design and development of computer software in the field of bioinformatic analysis; Design and development of computer software for visualisationanalysismanipulation of biological molecules; Design and development of computer software for modelling and prediction of biological interactions; Design and development of computer software for genome sequencing; Design and development of computer software for performing data analysis in the fields of medical diagnosisbiomarker discoverygenomicsbioinformatics; Design and development of computer software using artificial intelligence for machine learning in the field of genomics; Scientific research services for others in the field of genomics; Scientific research services for others in the field of drug discovery; Scientific research services for others in the field of medical diagnosis; Scientific research services for others in the field of biomarker discovery; Scientific research services for others in the field of bioinformatics; Scientific research consulting services in the field of drug discovery; Scientific research consulting services in the field of medical diagnosis; Scientific research consulting services in the field of biomarker discovery; Scientific research consulting services in the field of genomics; Scientific research consulting services in the field of bioinformatics; Scientific and technological servicesscientific research and analysis featuring profiling three-dimensional genome folding at high resolution for all genes and their enhancersin the field of genomics; Scientific and technological servicesscientific testing in the field of drug discovery; Scientific and technological servicesscientific testing in the field of medical diagnosis; Scientific and technological servicesscientific testing in the field of biomarker discovery; Scientific and technological servicesscientific testing in the field of genomics; Scientific and technological servicesscientific testing in the field of bioinformatics; Computer programming services for scientific data processing; Providing temporary use of on-line non-downloadable software for profiling three-dimensional genome folding at high resolution for all genes and their enhancers; Compiling data for research purposes in the field of medical science; Advisory services relating to computer software design for genomic analysis; Consultancy in the field of software design for genomic analysis; Providing information in the field of scientific research in the field of genomics; Compiling data for scientific research purposes in the field of medical science
Publications
History of USPTO decisions and trademark events.
33 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2025
PUBO
PUBLISHED FOR OPPOSITION
06/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/08/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/08/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/11/2025
GNRT
NON-FINAL ACTION E-MAILED
01/11/2025
CNRT
NON-FINAL ACTION WRITTEN
01/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/02/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
09/03/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
09/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/03/2024
GNRT
NON-FINAL ACTION E-MAILED
06/03/2024
CNRT
NON-FINAL ACTION WRITTEN
06/03/2024
DOCK
ASSIGNED TO EXAMINER
04/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/13/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
12/13/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
12/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/18/2023
GNRT
NON-FINAL ACTION E-MAILED
09/18/2023
CNRT
NON-FINAL ACTION WRITTEN
09/18/2023
DOCK
ASSIGNED TO EXAMINER
09/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/18/2022
NWAP
NEW APPLICATION ENTERED
11/29/2022
Continuous trademark protection
Get notified about every new filing that threatens GENLINK3D or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.